Neurochemical markers of neurodegeneration in the early diagnosis of Alzheimer's disease, vascular and mixed dementia

被引：0
|
作者：
Uspenskaya, O. V. [1 ]
Yakhno, N. N. [1 ]
Belushkina, N. N. [1 ]
机构：
[1] IM Sechenov Med Acad, Inst Mol Med, Moscow, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2010年 / 110卷 / 08期
关键词：
Alzheimer's disease; vascular dementia; mixed dementia; moderate cognitive impairment; neurodegeneration biomarkers; phosphorylated tau-protein; beta-amyloid-42; MILD COGNITIVE IMPAIRMENT; PHOSPHORYLATED TAU-PROTEIN; CSF TOTAL TAU; CEREBROSPINAL-FLUID; BIOMARKERS; PREVALENCE; RISK; LOAD;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A study of 27 patients with dismnestic variant of moderate cognitive impairment (MCI) and 20 patients with neurodynamic-dysregulatory variant was carried out. The more intensive atrophic process supported by neuroimaging data and changed levels of neurodegeneration biomarkers - phosphorylated tau-protein 181 and beta-amyloid 42 - were found in patients with dismnestic MCI variant. The follow-up study showed that the large number of patients with progressive cognitive disorders associated with conversion to dementia was observed in this group. In conclusion, the determination of the neurochemical markers in the cerebrospinal fluid allows to detect the neurodegenerative process at early stages of the disease and assists in detection of cases with increased risk of Alzheimer's disease.
引用
收藏
页码：36 / 40
页数：5
相关论文
共 50 条
  • [1] Neurochemical markers of Alzheimer's disease for early diagnosis and monitoring of disease progression
    Buerger, K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 29 - 29
  • [2] Neurochemical early and differential diagnosis of Alzheimer's dementia
    Wiltfang, J
    Lewczuk, P
    Maler, M
    Smirnov, A
    Kornhuber, J
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 273 - 273
  • [3] Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
    Ewers, Michael
    Sperling, Reisa A.
    Klunk, William E.
    Weiner, Michael W.
    Hampel, Harald
    TRENDS IN NEUROSCIENCES, 2011, 34 (08) : 430 - 442
  • [4] Retinal biomarkers for early diagnosis of vascular dementia and Alzheimer's disease
    Elo Agnes
    Czako Cecilia
    Istvan Lilla
    Benyo Fruzsina
    Nagy Zoltan Zsolt
    Kovacs Illes
    ORVOSI HETILAP, 2020, 161 (41) : 1744 - 1752
  • [5] Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia
    Boban, Marina
    Grbic, Kristina
    Mladinov, Mihovil
    Hof, Patrick R.
    Suessmair, Christine
    Ackl, Nibal
    Stanic, Gabrijela
    Bader, Benedikt
    Danek, Adrian
    Simic, Goran
    COLLEGIUM ANTROPOLOGICUM, 2008, 32 : 31 - 36
  • [6] Diagnosis of vascular dementia and Alzheimer's disease
    Román, G
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, : 9 - 13
  • [7] Is vascular dementia really Alzheimer's disease or mixed dementia?
    Gorelick, PB
    Nyenhuis, DL
    Garron, DC
    Cochran, E
    NEUROEPIDEMIOLOGY, 1996, 15 (06) : 286 - 290
  • [8] Inflammatory markers in Alzheimer's disease and vascular dementia
    Androsova, L. V.
    Mikhailova, N. M.
    Zozulya, S. A.
    Dupin, A. M.
    Rassadina, G. A.
    Lavrent'eva, N. V.
    Kliushnik, T. P.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (02) : 49 - 53
  • [9] Are neurochemical alterations the common denominator of Alzheimer's disease and vascular dementia?
    Lai, M. K. P.
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 85 - 85
  • [10] Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients
    Hatanaka, Hirokuni
    Hanyu, Haruo
    Fukasawa, Raita
    Hirao, Kentaro
    Shimizu, Soichiro
    Kanetaka, Hidekazu
    Iwamoto, Toshihiko
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2015, 15 : 53 - 58
12345